Abiomed chairman, president & CEO Mike Minogue testifies before the House of Representatives' Committee on Small Business that the impending 2.3% medical device tax will pose an extra burden on small businesses that "need every dollar to survive."
Abiomed (NSDQ:ABMD) chairman, president & CEO Mike Minogue took to Capitol Hill today to testify before the House of Representatives' Committee on Small Business, defending small medical device companies amid the burden they face as the medical device tax nears implementation.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...